TY  - BOOK
AU  - Ayat Abdelfataah Hassan Mohamed
AU  - Ghada Mohamed Nabeah , 
AU  - Maie Kamaleldein Helaly , 
AU  - Wafaa Taha Salem , 
TI  - Evaluation of dexmedetomidine as a sole agent  in sedation of cancer patients undergoing radiological interventional procedures / 
PY  - 2016///
CY  - Cairo : 
PB  - Ayat Abdelfataah Hassan Mohamed , 
KW  - Dexmedetomidine
KW  - Radiological interventional procedures
KW  - Sedation
N1  - Thesis (Ph.D.) - Cairo University - National Cancer Institute  - Department of Anaesthesia and Pain Relief; Issued also as CD
N2  - Dexmedetomidine is a potent and highly selective Ü-2 adrenoceptor agonist with  sympatholytic, sedative, amnestic, and analgesic properties which has been described as a  useful and safe adjunct in many clinical applications Uses of Dexmedetomidine are  continuously expanding; this gave us the motive to introduce it in one of the outpatient  fields which is the interventional radiological procedures. It provides unique 2conscious  sedation3 We observed an acceptable reduction (11% for blood pressure and 10% for  heart rate) after the loading dose of dexmedetomidine as compared to the pre sedation  values. In 61% of the cases in our study, adequate pain relief could be achieved only with  supplemental fentanyl. The diversity of interventional radiological procedures presented  in our study reflected the variance of how is it convenient to use dexmedetomidine in  these procedures. However, it still provides an alternative for anesthetists that has no  deleterious effects on respiration especially in the procedures where dexmedetomidine   gave proof to its efficacy in both sedation and analgesia
ER  -